Reaction
Hydrocele reporting signals
As of the last recalculation, Hydrocele appears in 1,052 FAERS reports alongside 23 co-occurring drug terms. The strongest observed disproportionality signal is ZIDOVUDINE (PRR 52.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Zidovudine | 34 | 52.0 | 52.1 |
| Tenofovir Disoproxil Fumarate Tablets | 17 | 39.6 | 39.7 |
| Efavirenz | 21 | 38.0 | 38.1 |
| Ritonavir 100 Mg | 19 | 25.6 | 25.6 |
| Dalteparin Sodium | 12 | 22.7 | 22.7 |
| Ritonavir | 32 | 22.3 | 22.3 |
| Finasteride | 63 | 21.9 | 21.9 |
| Valproate Sodium | 20 | 19.5 | 19.5 |
| Lamivudine | 28 | 18.4 | 18.4 |
| Lamivudine Oral | 22 | 17.6 | 17.6 |
| Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride | 7 | 15.8 | 15.8 |
| Tenofovir Disoproxil Fumarate | 22 | 13.4 | 13.4 |
| Cetirizine Hcl | 6 | 13.0 | 13.0 |
| Fondaparinux Sodium | 5 | 12.3 | 12.3 |
| Levetiracetam In Sodium Chloride | 46 | 12.2 | 12.2 |
| Levetiracetam Oral | 46 | 12.2 | 12.2 |
| Levetiracetam Injection | 46 | 12.2 | 12.2 |
| Tofacitinib Citrate | 8 | 12.2 | 12.2 |
| Vigabatrin | 8 | 10.9 | 10.9 |
| Emicizumab | 5 | 8.0 | 8.0 |
| Palivizumab | 6 | 7.8 | 7.8 |
| Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride And Dextrose | 3 | 7.3 | 7.3 |
| Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride | 11 | 7.1 | 7.1 |